BeiGene & SpringWorks Present Clinical Data Lifirafenib, in ComBO Mirdametinib
17 Apr 2023 //
BUSINESSWIRE
SpringWorks & BeiGene Present Clinical Data on Lifirafenib, combo Mirdametinib
17 Apr 2023 //
GLOBENEWSWIRE
SpringWorks Announces of Phase 1b Clinical Trial of MEK Inhibitor PD-0325901
06 May 2019 //
BUSINESSWIRE
SpringWorks names a CEO, inks a combo therapy deal with BeiGene
06 Sep 2018 //
FIERCE BIOTECH